Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn’s Disease Who Lost Response to Maintenance Therapy
2017 ◽
Vol 2
(4)
◽
pp. 228-235
◽
Keyword(s):
2018 ◽
Vol 12
(supplement_1)
◽
pp. S314-S314
Keyword(s):
Keyword(s):
2016 ◽
Vol 10
(suppl 1)
◽
pp. S17-S18
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 9
(2)
◽
pp. 84-88
◽
Keyword(s):